Soligenix (SNGX)

Discussion in 'Stock Message Boards NYSE, NASDAQ, AMEX' started by Biotechmaster, Jun 25, 2020.

  1. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    293
    Likes Received:
    10
    CHEAPEST Covid 19 Vaccine gem ....

    Low valuation of 49 million --has 3x Phase 3 programs with Data in Q4 / and a Covid 19 Vaccine programm with data coming soon ..has potential to move like INO or NVAX ...

    Soligenix (SNGX)

    Marekt Cap $50 Million
    Price: $1.89

    Shares Out 26. 6 M


    Presentation
    http://ir.soligenix.com/download/Soligenix+Corporate+Presentation+06.24.20FINAL.pdf

    Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX942 for the Treatment of Oral Mucositis
    https://finance.yahoo.com/news/soligenix-completes-enrollment-pivotal-phase-110000377.html

    Final top-line results expected Q4 2020


    SNGX: Q&A on COVID-19 Vaccine Candidate CiVax™…
    https://finance.yahoo.com/news/sngx-q-covid-19-vaccine-093900828.html

    As a reminder, following the positive topline data presented by the company for SGX-301 in CTCL, we continue to anticipate Phase 3 data for SGX-942 in oral mucositis in the fourth quarter of 2020. The company will also be joining the Russell Microcap Index effective June 29th, 2020, which should help to increase visibility within the investment community. Our current valuation is $12 per share.
     
  2. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    293
    Likes Received:
    10
  3. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    293
    Likes Received:
    10
  4. Biotechmaster

    Biotechmaster Member

    Joined:
    Jun 3, 2016
    Messages:
    293
    Likes Received:
    10

Share This Page